Forschungsprojekte
Ergebnisse pro Seite:
100
2022 - 2023
Large optic discs in children versus large optic discs in adults: Is there a difference?- Univ.-Prof. Dr. Esther M. Hoffmann
2022 - 2029
Nivolumab in combination with cisplatin and 5-fluorouracil as induction therapy in children and adults with EBV-positive nasopharyngeal carcinoma- PD Dr. med. habil. Olaf Beck,
- Univ.-Prof. Dr. med. Jörg Faber
2021 - 2024
Pathomechanisms of native tear protein complexes in dry eye syndrome- Dr. Natarajan Perumal
2021 - 2022
Influence of the protease activity of the mitochondrial protein HTRA2 on autophagy and respiratory activity of neuroretinal cells.- Dr. Carsten Schmelter
2021 - 2023
Comparison of 360° Trabeculotomy versus probe trabeculotomy in newborn and infants witt glaucoma- Univ.-Prof. Dr. Esther M. Hoffmann
2020 - 2021
Identification of new protein tyrosine nitration sites as promising biomarker candidates in the pathogenesis of glaucoma- Dr. Carsten Schmelter,
- Prof. Dr. Dr. Franz Grus
2020 - 2021
Retrospektive Auswertung von 5 Jahren Glaukomdiagnostik mittels PANO in Kamerun- Dr. Sylvain El-Khoury
2020
Ophthalmic care in intermediate AMD and its impact on daily life - Results from the general population- Univ.-Prof. Dr. Alexander Schuster
2019 - 2020
A Multi Center, Randomized, Double-Masked, Active-Controlled, Comparative Clinical Study to Evaluate the Efficacy and Safety of MYL-1701P and Eylea® in Subjects with Diabetic Macular Edema- PD Dr. Dr. Katrin Lorenz,
- Dr. Bert Constantin Giers
2019 - 2022
RAPTOR: An Eighteen-Month, Two-Arm, Randomized, Double-- PD Dr. Dr. Katrin Lorenz,
- Dr. Bert Constantin Giers,
- Dr. Anna Beck
2019 - 2020
Efficacy and safety assessment of T4032 (unpreserved bimatoprost 0.01%)- PD Dr. Dr. Katrin Lorenz
2019 - 2023
Keratoconjunctivitis Sicca: The importance of protein glycosylation for tear film stability- Prof. Dr. Dr. Franz Grus,
- Univ.-Prof. Dr. Norbert Pfeiffer
2019 - 2022
EyeBIS Study: The interdisciplinary prospective clinicial trial evaluating the influence of general anaesthesia on intraocular pressure- Univ.-Prof. Dr. Esther M. Hoffmann,
- Dr. Nina Pirlich
2018 - 2021
PANDA-1 A Multicenter, Double-Masked, Randomized,- PD Dr. Dr. Katrin Lorenz,
- Dr. Anna Beck
2018 - 2025
Effect of a combination of unpreserved trehalose and sodium hyaluron on the tear proteome in patients with dry eye disease- Prof. Dr. Dr. Franz Grus
2018 - 2023
Measurement of novel tear fluid biomarkers in increasingly prevalent retinal eye diseases: Improving diagnostic in AMD, DR/DME and glaucoma- Prof. Dr. Dr. Franz Grus
2018 - 2020
INCB 54828-201: A Phase 2, Open-label, Single Agent, Multi-Center Study to Evaluate the Efficacy and Safety of a Pan-FGFR Tyrosine Kinase Inhibitor INCB054828 in Patients with Metastatic or Surgically Unresectable Urothelial Carcinoma Harboring FGF/FGFR Alterations- Prof. Dr. Igor Tsaur,
- PD Dr. Thomas Höfner,
- PD Dr. Wolfgang Jäger
2018 - 2019
FORT-1:Phase 2/3 study of rogaratinib (BAY 1163877) vs chemotherapy in patients with FGFR-positive locally advanced or metastatic urothelial carcinoma- Prof. Dr. Georg Bartsch,
- Prof. Dr. Igor Tsaur,
- PD Dr. Thomas Höfner
2018 - 2022
FORT-2: Phase 1b/2 study of rogaratinib (BAY 1163877) in combination with atezolizumab in urothelial carcinoma- Prof. Dr. Georg Bartsch,
- Prof. Dr. Igor Tsaur,
- PD Dr. Thomas Höfner
2018 - 2019
Characterization of the functional role(s) of proline-rich protein 4 (PRR4) in ameliorating dry eye disease in an in vitro hyperosmotic human corneal epithelial cell model- Dr. Natarajan Perumal,
- Prof. Dr. Dr. Franz Grus
2018 - 2020
ISM04EU - A PROSPECTIVE, OPEN, MULTICENTRE CLINICAL TRIAL WITH ONE COHORT ANALYSING THE EFFICACY AND SAFETY OF MINIJECT IN EUROPEAN PATIENTS WITH OPEN ANGLE GLAUCOMA UNCONTROLLED BY TOPICAL HYPOTENSIVE MEDICATIONS- Prof. Dr. Norbert Pfeiffer,
- Dr. Katharina Bell,
- PD Dr. Katrin Lorenz
2018 - 2022
The (patho)physiological role(s) of CYP450-mediated mechanism(s) in the ophthalmic artery- Dr. Caroline Manicam
2017 - 2021
Implementation of optimized childhood vision and hearing screening programms in middle-income countries in Europe- Dr. Heike Elflein,
- Prof. Dr. Norbert Pfeiffer
2017
Fundus hypertonicus as risk factor for cardiovascular events - the Gutenberg Health Study- Dr. Alexander K. Schuster
2017
Visual impairment and blindness in the Gutenberg Health Study (GHS)- Christian Wolfram,
- Norbert Pfeiffer
2017 - 2023
Establishment of a national register for congenital glaucoma in Germany- Univ.-Prof. Dr. Esther M. Hoffmann
2017
PANORAMA - A phase 3, double-masked, randomized study of the efficacy and safety of intravitreal aflivercept injections in patients with moderately sever to severe nonproliferative diabetic retinopathy- Prof. Dr. Norbert Pfeiffer,
- Dr. Katharina Bell
2017 - 2018
Distribution and associated factors of tear fluid quantity in the general population - Results from the Gutenberg Health Study (GHS)- PD Dr. Ulrike Hampel,
- Dr. Alexander Schuster,
- Prof. Dr. Norbert Pfeiffer
2017 - 2018
Anterior segment morphology and axial length in relation to self-reported birth weight in the Gutenberg Health Study (GHS)- Dr. Achim Fieß,
- Univ.-Prof. Dr. Norbert Pfeiffer
2017 - 2018
Vision-related Quality of Life in relation to visual acuity in both eyes in the Gutenberg Health Study (GHS)- Dr. Stefan Nickels,
- Univ.-Prof. Dr. Norbert Pfeiffer
2017 - 2018
Association of autoantibody levels with different stages of age-related macular degeneration (AMD): Results from the Gutenberg Health Study (GHS)- Dr. Christina Korb,
- Dominik Wolters,
- Univ.-Prof. Dr. Franz Grus,
- Univ.-Prof. Dr. Norbert Pfeiffer
2017
Prevalence and Assessment of Depression and Anxiety among Participants with Glaucoma in a Population-based Cohort Study: The Gutenberg Health Study- Dr. Jasmin Rezapour,
- Univ.-Prof. Dr. Manfred Beutel
2016 - 2017
VIOLET (17613): Efficacy and safety of three different Eylea regimens in subjects with DME- PD Dr. Katrin Lorenz
2016 - 2018
BI 1320.22DME: Safety and effect on central retinal thickness of BI 1026706 in patients with diabetic macular edema- Dr. Katharina Bell,
- PD Dr. Katrin Lorenz
2016 - 2019
ALBATROS - Data collection on the care situation and quality of life of patients with anti-VEGF treatment in neovascular AMD, diabetic macular edema or retinal venous occlusion- Dr. Christina Korb,
- PD Dr. Katrin Lorenz
2016 - 2017
Visual function in relation to birth weight in the Gutenberg Health Study- Univ.-Prof. Dr. Norbert Pfeiffer,
- Dr. Achim Fieß
2016 - 2017
Prevalence and Assessment of Depression and Anxiety among Participants with Glaucoma in a Population-based Cohort Study: The Gutenberg Health Study- Jasmin Rezapour,
- Norbert Pfeiffer,
- Manfred Beutel
2016 - 2017
Visual function in relation to birth weight – results from the population-based Gutenberg Health Study (GHS)- Achim Fieß,
- Norbert Pfeiffer
2016 - 2017
Choroidal thickness and the continuum of heart failure – The Gutenberg Health Study- Alexander Schuster,
- Norbert Pfeiffer,
- Philipp Wild
2016 - 2017
Distribution of iris configuration and dependency on age, refraction and lens thickness – The Gutenberg Health Study- Alexander Schuster,
- Norbert Pfeiffer
2016 - 2017
Visuospatial planning skills in amblyopic persons: Results from the Gutenberg Health Study- Heike Elflein,
- Norbert Pfeiffer,
- Josef Unterrainer
2016 - 2017
Association of serum homocysteine levels and myopia – results from the Gutenberg Health Study- Stefan Nickels,
- Norbert Pfeiffer,
- Henk Blom,
- Wolf Lagrèze
2016 - 2018
BI 1320.22: Safety and effect on central retinal thickness of BI 1026706 in patients with diabetic macular edema- PD Dr. Katrin Lorenz
2015 - 2018
Beeinflusst die kinderärztliche Vorsorgeuntersuchung U7a die Augenbefunde bei den Schuleingangsuntersuchungen?- Dr. Heike Elflein
2015 - 2018
COLUMBUS-AMD (FYB201-C2015-01-P3): EFFICACY AND SAFETY OF THE BIOSIMILAR RANIBIZUMAB FYB201 IN COMPARISON TO LUCENTIS IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION- Dr. Katharina Bell,
- PD Dr. Katrin Lorenz
2015 - 2017
Vision-related Quality of Life in the Gutenberg Health Study (GHS)- Dr. Stefan Nickels,
- Dr. Alexander Schuster,
- Univ.-Prof. Dr. Norbert Pfeiffer
2015 - 2018
Simbrinza GLH694-P001: Additive Effect of Twice Daily Brinzolamide 1% /Brimonidine 0.2% Fixed Dose Combination as an Adjunctive Therapy to a Prostaglandin Analogue.- Dr. Katharina Bell,
- PD Dr. Katrin Lorenz
2015 - 2020
Artemis - Bimatoprost 192024_092: The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension- Dr. Katharina Bell,
- PD Dr. Katrin Lorenz
2015 - 2020
PACIFIC CRFB002ADE28 - Observation of treatment regimens with lucentis during every day treatment in all approved indications- PD Dr. Katrin Lorenz
2015 - 2018
Lampalizumab GX29185: A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE-MASKED, SHAM-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF LAMPALIZUMAB ADMINISTERED INTRAVITREALLY TO PATIENTS WITH GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION- Dr. Katharina Bell,
- PD Dr. Katrin Lorenz
2015 - 2016
IRISS: AN OPEN LABEL, REGISTRY STUDY OF THE SAFETY OF ILUVIEN® 190 MICROGRAMS INTRAVITREAL IMPLANT IN APPLICATOR- Prof. Dr. Norbert Pfeiffer